menu
    • menu

    Company profile for Aculys Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ACULYS is a private biopharma company focused on the development and commercialization of innovative, best-in-class therapeutics. We specialize in CNS and are committed to helping patients in Japan who are suffering from debilitating neurologic diseases improve their quality of life. Aculys is developing a new medicine in Japan for patients suffering from Narcolepsy and other sleep disorders. We are also continuously exploring...
    ACULYS is a private biopharma company focused on the development and commercialization of innovative, best-in-class therapeutics. We specialize in CNS and are committed to helping patients in Japan who are suffering from debilitating neurologic diseases improve their quality of life. Aculys is developing a new medicine in Japan for patients suffering from Narcolepsy and other sleep disorders. We are also continuously exploring opportunities to discover other innovations to address the unmet needs of patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aculys Pharmajapan Flag
    Country
    Country
    Japan
    Address
    Address
    26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa-ken
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aculys.com/en/home-en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Viatris Completes Acquisition of Aculys Pharma
    Viatris Completes Acquisition of Aculys Pharma

    15 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-completes-acquisition-of-aculys-pharma-including-exclusive-rights-to-pitolisant-in-japan-and-to-spydia-in-japan-and-certain-other-markets-in-the-asia-pacific-region-302585421.html

    PR NEWSWIRE
    15 Oct 2025
    Share Share
    Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO
    Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO

    01 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aculys-pharma-announces-appointment-of-hidemasa-tanigaki-as-new-ceo-302104178.html

    PR NEWSWIRE
    01 Apr 2024
    Share Share
    Aculys delivers positive Phase 3 study interim analysis result of a diazepam
    Aculys delivers positive Phase 3 study interim analysis result of a diazepam

    18 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aculys-pharma-delivers-positive-phase-3-clinical-study-interim-analysis-result-of-a-diazepam-nasal-spray-an-antiepileptic-drug-for-the-treatment-of-epileptic-seizures-301959812.html

    PR NEWSWIRE
    18 Oct 2023
    Share Share
    Aculys Pharma and Four H Initiate Research Collaboration
    Aculys Pharma and Four H Initiate Research Collaboration

    24 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230124006076/en

    BUSINESSWIRE
    24 Jan 2023
    Share Share
    Aculys Pharma Initiates Phase 3 Trial of Pitolisant
    Aculys Pharma Initiates Phase 3 Trial of Pitolisant

    24 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230124005930/en

    BUSINESSWIRE
    24 Jan 2023
    Share Share
    Aculys Pharma and SUSMED Sign Contract for Trial Utilizing Blockchain Technology
    Aculys Pharma and SUSMED Sign Contract for Trial Utilizing Blockchain Technology

    12 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220712005584/en

    BUSINESSWIRE
    12 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search